Bio Capital Impact Fund

Bio Capital Impact Fund is an open-ended, evergreen fund managed from Australia, with satellite offices in other regions. It has no sunset date and no cap on its size, so it can make investments as opportunities arise.

The fund invests in biotechnology that it believes improves lives or benefits society. It says impact is judged by internationally accredited organisations.

Products and services

• Later-stage biotech investment: diversified, international, high-growth holdings.
• Ongoing support: capital and strategic help for its investments.
• Flexible structure: reinvestment pathways, and bespoke terms for significant long-term investors.
• Alliances: collaborations with pharmaceutical companies, medical research institutes and universities.

Clients

Investors with a long-term view, and biotech companies in medical, agricultural and industrial fields.

Key facts

• Managed from: Australia
• Structure: evergreen, open-ended fund
• Team experience: commercialisation, licensing, fund development and investment management across Asia, Europe and North America